Semaglutide

Price range: £40.00 through £110.00

CAS: 910463-68-2

Strengths Available:  10mg/30mg
Format: Sealed containment / vial presentations available
Volume: 3mL

What Semaglutide is about?
Research vial, supplied as a lyophilised powder Semaglutide is frequently referenced in research focused on metabolic regulation, energy balance, and body-composition science. It has attracted scientific attention as a research tool for exploring how metabolic and appetite-signalling pathways are regulated. Semaglutide is a research-grade peptide studied in the context of metabolic signalling, energy balance, and related receptor pathways. Investigators have explored how Semaglutide interacts with pathways relevant to glucose handling, appetite regulation, or lipid metabolism in laboratory models.

SKU: N/A Category:

Description

What is Semaglutide?

Semaglutide is a long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist developed to mimic the action of naturally occurring GLP-1 hormones involved in appetite regulation, glucose control and energy metabolism.

Researchers continue to investigate Semaglutide across a broad range of metabolic and physiological pathways, including:

  • Weight-management research
  • Appetite-regulation pathways
  • Metabolic signalling
  • GLP-1 receptor activity
  • Energy-balance mechanisms
  • Glucose-metabolism studies
  • Endocrine research
  • Obesity-related pathways
  • Cardiometabolic research

Its extended duration of action and substantial scientific literature have made Semaglutide one of the most widely recognised compounds within metabolic research.

 

Why Semaglutide Attracted Research Interest

Semaglutide has become one of the most widely investigated GLP-1 receptor agonists due to its extensive scientific literature and relevance to metabolic research.

Researchers continue to investigate Semaglutide because of its involvement in pathways associated with appetite signalling, glucose regulation, gastric emptying and energy homeostasis.

Areas commonly explored include:

  • GLP-1 receptor signalling
  • Metabolic regulation
  • Energy balance mechanisms
  • Appetite-related pathways
  • Glucose metabolism
  • Cardiometabolic research
  • Endocrine function studies
  • Long-term metabolic adaptation research

What the Research Has Shown

Its prolonged activity profile allows researchers to investigate sustained receptor activation and long-term metabolic responses, contributing to its position as one of the most recognised compounds within GLP-1 research.

Fast Secure Shipping
Independently Verified
Trusted by 1000s of customers
Manufactured in the U.K.

Scientific Background and Research Context

Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, commonly known as GLP-1. GLP-1 is an incretin hormone involved in glucose regulation, appetite signalling, gastric emptying, and metabolic homeostasis. Semaglutide belongs to the class of GLP-1 receptor agonists, which are designed to activate the GLP-1 receptor and support research into metabolic regulation, body-composition science, and energy-balance pathways.

Semaglutide became a major focus of metabolic research because GLP-1 signalling connects several biological systems that are central to energy balance. These include pancreatic insulin secretion, glucagon regulation, appetite-related brain pathways, gastrointestinal motility, and nutrient-handling mechanisms. Research into GLP-1 receptor agonists has shown that this pathway is relevant not only to glucose metabolism, but also to broader questions involving body weight, satiety, cardiometabolic risk, and long-term metabolic health.

Exploring the Science Behind GLP-1

GLP-1 is naturally released after food intake and helps coordinate the body’s response to nutrients. In research models and clinical studies, GLP-1 receptor activation has been associated with increased glucose-dependent insulin secretion, reduced glucagon release, delayed gastric emptying, and central appetite modulation. These combined effects make the GLP-1 pathway an important area of investigation in metabolic and endocrine science.

Research Context in Metabolic and Body-Composition Science

Semaglutide has been studied extensively in relation to obesity, type 2 diabetes, and cardiometabolic outcomes. In the STEP 1 trial, once-weekly semaglutide with lifestyle intervention was associated with substantial weight reduction in adults with overweight or obesity without diabetes, with a reported mean weight loss of 14.9% over 68 weeks.

Beyond body-weight research, semaglutide has also been investigated in relation to cardiovascular and metabolic outcomes. GLP-1 receptor agonist research continues to explore how this class may influence inflammation, lipid handling, hepatic metabolism, renal outcomes, and cardiovascular risk pathways, although mechanisms and long-term effects remain active areas of study.

Ongoing Scientific Interest

The continued interest in semaglutide reflects the broader scientific movement toward understanding metabolism as an integrated system rather than a single pathway. Researchers are examining how GLP-1 receptor activation may influence appetite regulation, insulin sensitivity, energy intake, adipose tissue biology, gastrointestinal signalling, and cardiometabolic markers.

  • GLP-1 pathway biology
  • Appetite signalling mechanisms
  • Metabolic regulation
  • Energy balance research
  • Body composition science
  • Gastrointestinal physiology
  • Gut-brain communication pathways
  • Cellular energy utilisation
  • Healthy ageing research
  • Metabolic health and longevity science

Semaglutide therefore remains an important reference compound in modern metabolic research, especially for studies focused on GLP-1 biology, glucose regulation, satiety signalling, and body-composition science.

For research and laboratory use only. Not for human or veterinary use.

Ingredient Profile
Single research compound: Semaglutide. CAS: 910463-68-2. Purity >99%. Supplied as lyophilised powder (no excipients, fillers or additives).

Active Ingredients
Semaglutide — 5mg / 10mg

Ingredient Breakdown
Semaglutide: 5mg / 10mg of active peptide per vial (lyophilised).

Why is Semaglutide studied in metabolic research?
Because studies have explored its relevance to metabolic regulation and energy-balance pathways.
Is Semaglutide approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.
Why does purity matter so much for this
product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.
What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.
Is international supply available?
Yes. International fulfilment and temperature-controlled shipping can be supported where appropriate.

 

Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.

Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.

Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.

For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.

Partner with FreshstartPharma– Where Accuracy Meets Innovation

Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.